FDA paves way for Pfizer COVID-19 vaccinations in young kids
The Hindu
Up to 28 million more American children could be eligible for vaccinations as early as next week
The Food and Drug Administration (FDA) on October 29 paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine.
The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
One more regulatory hurdle remains: On November 2, advisers to the Centers for Disease Control and Prevention will make more detailed recommendations on which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterwards.
Prosecutor says Trump tried 'to hoodwink voters' while defence attacks key witness in last arguments
Prosecutors accuse Trump of conspiracy in hush money trial, defense calls star witness "greatest liar of all time."